Due to the continuously growing understanding of the cellular context-dependency of TGF-β signaling together with advancement of diagnosis and follow up procedures for patients with liver fibrosis, we believe that TGF-β based therapeutics have a chance to become reality in the near future. The gene discussed is TGFB1; the disease is Hepatic fibrosis.